Drug-Induced Delirium Associated With Sacubitril/Valsartan in a Patient With Chronic Kidney Disease: A Case Report

Drug-induced neuropsychiatric symptoms are not uncommon, particularly in patients with multiple comorbidities and polypharmacy. Sacubitril/valsartan is a combination medication used in the treatment of heart failure, especially for reducing hospitalizations in patients with heart failure with preserved ejection fraction (HFpEF). However, its neurological side effects, including delirium, hallucinations, and confusion, have been increasingly reported. This case report explores the occurrence of drug-induced delirium, specifically visual hallucinations, in a 79-year-old male with HFpEF and end-stage kidney disease (ESKD) after starting sacubitril/valsartan.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-10-28
DOI
https://doi.org/10.7759/cureus.72524
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-Induced Delirium Associated With Sacubitril/Valsartan in a Patient With Chronic Kidney Disease: A Case Report

Óscar Alberto Pérez Peña, Kim Kyung
Cureus
Epilepsy research and treatment
article

Drug-Induced Delirium Associated With Sacubitril/Valsartan in a Patient With Chronic Kidney Disease: A Case Report

Óscar Alberto Pérez Peña, Kim Kyung
article en

Abstract

Drug-induced neuropsychiatric symptoms are not uncommon, particularly in patients with multiple comorbidities and polypharmacy. Sacubitril/valsartan is a combination medication used in the treatment of heart failure, especially for reducing hospitalizations in patients with heart failure with preserved ejection fraction (HFpEF). However, its neurological side effects, including delirium, hallucinations, and confusion, have been increasingly reported. This case report explores the occurrence of drug-induced delirium, specifically visual hallucinations, in a 79-year-old male with HFpEF and end-stage kidney disease (ESKD) after starting sacubitril/valsartan.

CureusVol. 16(10)
University of Bridgeport (US), St. Vincent's Medical Center (US)
Good health and well-being
Openalex Percentile: Top 74%
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.